Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies.
暂无分享,去创建一个
[1] A. Monto,et al. Enhanced Genetic Characterization of Influenza A(H3N2) Viruses and Vaccine Effectiveness by Genetic Group, 2014-2015. , 2016, The Journal of infectious diseases.
[2] F. Pozo,et al. Interim influenza vaccine effectiveness: A good proxy for final estimates in Spain in the seasons 2010-2014. , 2015, Vaccine.
[3] L. Blumberg,et al. Evaluation of influenza vaccine effectiveness and description of circulating strains in outpatient settings in South Africa, 2014 , 2015, Influenza and other respiratory viruses.
[4] D. Skowronski,et al. Integrated Sentinel Surveillance Linking Genetic, Antigenic, and Epidemiologic Monitoring of Influenza Vaccine-Virus Relatedness and Effectiveness During the 2013-2014 Influenza Season. , 2015, The Journal of infectious diseases.
[5] S. de Lusignan,et al. Effectiveness of seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2015/16 mid-season results. , 2015, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[6] D. Skowronski,et al. Interim estimates of 2014/15 vaccine effectiveness against influenza A(H3N2) from Canada's Sentinel Physician Surveillance Network, January 2015. , 2015, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[7] Richard K. Zimmerman,et al. Early Estimates of Seasonal Influenza Vaccine Effectiveness — United States, January 2015 , 2015, MMWR. Morbidity and mortality weekly report.
[8] H. Kelly,et al. Understanding influenza vaccine protection in the community: an assessment of the 2013 influenza season in Victoria, Australia. , 2015, Vaccine.
[9] E. R. van den Heuvel,et al. Effectiveness of seasonal influenza vaccine in community-dwelling elderly people: a meta-analysis of test-negative design case-control studies. , 2014, The Lancet. Infectious diseases.
[10] Richard K. Zimmerman,et al. Influenza Vaccine Effectiveness in the United States During 2012–2013: Variable Protection by Age and Virus Type , 2014, The Journal of infectious diseases.
[11] Benjamin J Cowling,et al. Potential of the test-negative design for measuring influenza vaccine effectiveness: a systematic review , 2014, Expert review of vaccines.
[12] G. Dowse,et al. Influenza vaccine effectiveness estimates for Western Australia during a period of vaccine and virus strain stability, 2010 to 2012. , 2014, Vaccine.
[13] H. Kelly,et al. Interim estimates of the effectiveness of seasonal trivalent inactivated influenza vaccine in preventing influenza hospitalisations and primary care visits in Auckland, New Zealand, in 2014. , 2014, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[14] T. Friedrich,et al. Impact of Repeated Vaccination on Vaccine Effectiveness Against Influenza A(H3N2) and B During 8 Seasons , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[15] P. Yang,et al. Influenza vaccine effectiveness against medically-attended influenza illness during the 2012-2013 season in Beijing, China. , 2014, Vaccine.
[16] H. Kelly,et al. Effectiveness of seasonal trivalent inactivated influenza vaccine in preventing influenza hospitalisations and primary care visits in Auckland, New Zealand, in 2013. , 2014, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[17] F. Pozo,et al. Higher vaccine effectiveness in seasons with predominant circulation of seasonal influenza A(H1N1) than in A(H3N2) seasons: test-negative case-control studies using surveillance data, Spain, 2003-2011. , 2014, Vaccine.
[18] C Moore,et al. Effectiveness of trivalent seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2012/13 end of season results. , 2014, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[19] D. Skowronski,et al. Influenza A/subtype and B/lineage effectiveness estimates for the 2011-2012 trivalent vaccine: cross-season and cross-lineage protection with unchanged vaccine. , 2014, The Journal of infectious diseases.
[20] N. Stocks,et al. Influenza vaccine effectiveness in Australia: results from the Australian Sentinel Practices Research Network , 2014, The Medical journal of Australia.
[21] H. Kelly,et al. Influenza vaccine effectiveness during the 2012 influenza season in Victoria, Australia: Influences of waning immunity and vaccine match , 2014, Journal of medical virology.
[22] Jose L. Sanchez,et al. Brief report: mid-season influenza vaccine effectiveness estimates for the 2013-2014 influenza season. , 2014, MSMR.
[23] D. Skowronski,et al. Low 2012–13 Influenza Vaccine Effectiveness Associated with Mutation in the Egg-Adapted H3N2 Vaccine Strain Not Antigenic Drift in Circulating Viruses , 2014, PloS one.
[24] A. Monto,et al. Interim Estimates of 2013–14 Seasonal Influenza Vaccine Effectiveness — United States, February 2014 , 2014, MMWR. Morbidity and mortality weekly report.
[25] F. Pozo,et al. Vaccine effectiveness in preventing laboratory-confirmed influenza in Navarre, Spain: 2013/14 mid-season analysis. , 2014, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[26] U. Buchholz,et al. Influenza vaccine effectiveness estimates in Europe in a season with three influenza type/subtypes circulating: the I-MOVE multicentre case-control study, influenza season 2012/13. , 2014, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[27] A. Monto,et al. Influenza vaccine effectiveness in the 2011-2012 season: protection against each circulating virus and the effect of prior vaccination on estimates. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[28] C. Robertson,et al. Estimates of influenza vaccine effectiveness in primary care in Scotland vary with clinical or laboratory endpoint and method--experience across the 2010/11 season. , 2013, Vaccine.
[29] T. Vega,et al. Effectiveness of influenza vaccine against laboratory-confirmed influenza, in the late 2011–2012 season in Spain, among population targeted for vaccination , 2013, BMC Infectious Diseases.
[30] H. Kelly,et al. Stratified estimates of influenza vaccine effectiveness by prior vaccination: caution required. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[31] Michael Haber,et al. The case test-negative design for studies of the effectiveness of influenza vaccine. , 2013, Vaccine.
[32] Jennifer C Nelson,et al. The test-negative design for estimating influenza vaccine effectiveness. , 2013, Vaccine.
[33] E. Belongia,et al. Effectiveness of monovalent 2009 pandemic influenza A virus subtype H1N1 and 2010-2011 trivalent inactivated influenza vaccines in Wisconsin during the 2010-2011 influenza season. , 2013, The Journal of infectious diseases.
[34] J. Castilla,et al. Effectiveness of the trivalent influenza vaccine in Navarre, Spain, 2010–2011: a population-based test-negative case–control study , 2013, BMC Public Health.
[35] Wen-Ta Chiu,et al. Surveillance and Vaccine Effectiveness of an Influenza Epidemic Predominated by Vaccine-Mismatched Influenza B/Yamagata-Lineage Viruses in Taiwan, 2011−12 Season , 2013, PloS one.
[36] J. Castilla,et al. Early estimates of influenza vaccine effectiveness in Navarre, Spain: 2012/13 mid-season analysis. , 2013, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[37] F. Pozo,et al. Decline in influenza vaccine effectiveness with time after vaccination, Navarre, Spain, season 2011/12. , 2013, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[38] M. Valenciano,et al. Low and decreasing vaccine effectiveness against influenza A(H3) in 2011/12 among vaccination target groups in Europe: results from the I-MOVE multicentre case-control study. , 2013, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[39] D. Fleming,et al. Vaccine effectiveness of 2011/12 trivalent seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: evidence of waning intra-seasonal protection. , 2013, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[40] W. Hautmann,et al. Effectiveness of trivalent and monovalent influenza vaccines against laboratory-confirmed influenza infection in persons with medically attended influenza-like illness in Bavaria, Germany, 2010/2011 season , 2012, Epidemiology and Infection.
[41] A. Monto,et al. Effectiveness of seasonal influenza vaccines in the United States during a season with circulation of all three vaccine strains. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[42] D. Skowronski,et al. Estimates of influenza vaccine effectiveness for 2007-2008 from Canada's sentinel surveillance system: cross-protection against major and minor variants. , 2012, The Journal of infectious diseases.
[43] W Carman,et al. Age-specific vaccine effectiveness of seasonal 2010/2011 and pandemic influenza A(H1N1) 2009 vaccines in preventing influenza in the United Kingdom , 2012, Epidemiology and Infection.
[44] F. Pozo,et al. Effectiveness of the 2010-11 seasonal trivalent influenza vaccine in Spain: cycEVA study. , 2012, Vaccine.
[45] D. Skowronski,et al. A sentinel platform to evaluate influenza vaccine effectiveness and new variant circulation, Canada 2010-2011 season. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[46] H. Kelly,et al. Moderate influenza vaccine effectiveness in Victoria, Australia, 2011. , 2012, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[47] C. Robertson,et al. Assessment of the Variability in Influenza A(H1N1) Vaccine Effectiveness Estimates Dependent on Outcome and Methodological Approach , 2011, PloS one.
[48] T. Vega,et al. Using surveillance data to estimate pandemic vaccine effectiveness against laboratory confirmed influenza A(H1N1)2009 infection: two case-control studies, Spain, season 2009-2010 , 2011, BMC public health.
[49] M. Valenciano,et al. I-MOVE Multi-Centre Case Control Study 2010-11: Overall and Stratified Estimates of Influenza Vaccine Effectiveness in Europe , 2011, PloS one.
[50] P. V. Van Caeseele,et al. Effectiveness of the pandemic H1N1 influenza vaccines against laboratory-confirmed H1N1 infections: population-based case-control study. , 2011, Vaccine.
[51] S. Lindstrom,et al. Influenza vaccine effectiveness in Wisconsin during the 2007-08 season: comparison of interim and final results. , 2011, Vaccine.
[52] A. Monto,et al. Effectiveness of Non-Adjuvanted Pandemic Influenza A Vaccines for Preventing Pandemic Influenza Acute Respiratory Illness Visits in 4 U.S. Communities , 2011, PloS one.
[53] J. Castilla,et al. Effectiveness of the monovalent influenza A(H1N1)2009 vaccine in Navarre, Spain, 2009-2010: cohort and case-control study. , 2011, Vaccine.
[54] H. Kelly,et al. Effectiveness of Seasonal Influenza Vaccine against Pandemic (H1N1) 2009 Virus, Australia, 2010 , 2011, Emerging infectious diseases.
[55] H. Kelly,et al. Estimation of type- and subtype-specific influenza vaccine effectiveness in Victoria, Australia using a test negative case control method, 2007-2008 , 2011, BMC infectious diseases.
[56] Xiyan Xu,et al. Serologic assays for influenza surveillance, diagnosis and vaccine evaluation , 2011, Expert review of anti-infective therapy.
[57] J. Noh,et al. Effectiveness of the pandemic influenza A/H1N1 2009 monovalent vaccine in Korea. , 2011, Vaccine.
[58] D. Skowronski,et al. Effectiveness of AS03 adjuvanted pandemic H1N1 vaccine: case-control evaluation based on sentinel surveillance system in Canada, autumn 2009 , 2011, BMJ : British Medical Journal.
[59] H. Kelly,et al. Vaccine Effectiveness Against Laboratory-confirmed Influenza in Healthy Young Children: A Case–Control Study , 2011, The Pediatric infectious disease journal.
[60] W Carman,et al. Effectiveness of pandemic and seasonal influenza vaccine in preventing pandemic influenza A(H1N1)2009 infection in England and Scotland 2009-2010. , 2011, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[61] M. Valenciano,et al. Estimates of Pandemic Influenza Vaccine Effectiveness in Europe, 2009–2010: Results of Influenza Monitoring Vaccine Effectiveness in Europe (I-MOVE) Multicentre Case-Control Study , 2011, PLoS medicine.
[62] D M Fleming,et al. Estimating influenza vaccine effectiveness using routinely collected laboratory data , 2009, Journal of Epidemiology & Community Health.
[63] M. Valenciano,et al. "I-MOVE" towards monitoring seasonal and pandemic influenza vaccine effectiveness: lessons learnt from a pilot multi-centric case-control study in Europe, 2008-9. , 2009, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[64] Yan Li,et al. Component-specific effectiveness of trivalent influenza vaccine as monitored through a sentinel surveillance network in Canada, 2006-2007. , 2009, The Journal of infectious diseases.
[65] D. Skowronski,et al. Estimating vaccine effectiveness against laboratory-confirmed influenza using a sentinel physician network: results from the 2005-2006 season of dual A and B vaccine mismatch in Canada. , 2007, Vaccine.
[66] A. Lapedes,et al. Mapping the Antigenic and Genetic Evolution of Influenza Virus , 2004, Science.
[67] Keiji Fukuda,et al. Mortality associated with influenza and respiratory syncytial virus in the United States. , 2003, JAMA.
[68] S. Thompson,et al. Quantifying heterogeneity in a meta‐analysis , 2002, Statistics in medicine.
[69] L. Simonsen,et al. The impact of influenza epidemics on mortality: introducing a severity index. , 1997, American journal of public health.
[70] N. Cox,et al. Nonimmunoselected intrastrain genetic variation detected in pairs of high-yielding influenza A (H3N2) vaccine and parental viruses. , 1994, The Journal of infectious diseases.
[71] N. Laird,et al. Meta-analysis in clinical trials. , 1986, Controlled clinical trials.
[72] S. de Lusignan,et al. Low effectiveness of seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2014/15 mid-season results. , 2015, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[73] Nicholas S. Kelley,et al. Effi cacy and eff ectiveness of infl uenza vaccines: a systematic review and meta-analysis , 2012 .
[74] K. Stöhr,et al. Influenza virus surveillance, vaccine strain selection, and manufacture. , 2012, Methods in molecular biology.
[75] Nicholas S. Kelley,et al. Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. , 2012, The Lancet. Infectious diseases.
[76] Effectiveness of vaccine against medical consultation due to laboratory-confirmed influenza: results from a sentinel physician pilot project in British Columbia, 2004-2005. , 2005, Canada communicable disease report = Releve des maladies transmissibles au Canada.